Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 304.36%583.29K | 2,542.30%207.02K | 220.41%1.98M | 443.40%1.17M | 105.52%330.71K | 18.06%144.25K | 7.84K | -23.02%617.93K | 215.09K | 160.91K |
| Selling and administrative expenses | -3.34%105.92K | 1,770.50%95.68K | 48.18%562.68K | -6.91%95.78K | 176.39%266.73K | 23.94%109.59K | --5.12K | -2.58%379.72K | --102.9K | --96.51K |
| -General and administrative expense | -3.34%105.92K | 1,770.50%95.68K | 48.18%562.68K | -6.91%95.78K | 176.39%266.73K | 23.94%109.59K | --5.12K | -2.58%379.72K | --102.9K | --96.51K |
| Other operating expenses | 1,277.15%477.36K | 3,993.68%111.35K | 494.94%1.42M | 856.42%1.07M | -0.67%63.98K | 2.66%34.66K | --2.72K | -42.31%238.22K | --112.19K | --64.41K |
| Operating profit | -304.36%-583.29K | -2,542.30%-207.02K | -220.41%-1.98M | -443.40%-1.17M | -105.52%-330.71K | -18.06%-144.25K | -7.84K | 23.02%-617.93K | -215.09K | -160.91K |
| Net non-operating interest income (expenses) | -102.66%-328 | -1.11K | 16.21%-832 | -34,332.11%-37.53K | 6,800.82%24.53K | 5,300.84%12.33K | 0 | -16.96%-993 | -109 | -366 |
| Non-operating interest income | ---- | ---- | ---- | ---- | --24.72K | --12.39K | ---- | ---- | ---- | --0 |
| Total other finance cost | 446.67%328 | --1.11K | -16.21%832 | 292.66%428 | -47.54%192 | -74.68%60 | ---- | 16.96%993 | --109 | --366 |
| Other net income (expenses) | 31.81K | 32.89K | -15,797.31%-1.72M | -15,343.06%-1.72M | 40 | -248.54%-10.84K | -11.16K | |||
| Gain on sale of security | --31.81K | --32.89K | 547.67%48.51K | 534.50%48.47K | --40 | ---- | ---- | -248.54%-10.84K | ---11.16K | ---- |
| Special income (charges) | ---- | ---- | --4.11K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---4.11K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---1.78M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -318.28%-551.8K | -2,136.68%-175.24K | -488.06%-3.7M | -1,194.01%-2.93M | -89.82%-306.15K | -7.76%-131.92K | -7.84K | 21.93%-629.76K | -226.35K | -161.28K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -318.28%-551.8K | -2,136.68%-175.24K | -488.06%-3.7M | -1,194.01%-2.93M | -89.82%-306.15K | -7.76%-131.92K | -7.84K | 21.93%-629.76K | -226.35K | -161.28K |
| Net income continuous operations | -318.28%-551.8K | -2,136.68%-175.24K | -488.06%-3.7M | -1,194.01%-2.93M | -89.82%-306.15K | -7.76%-131.92K | ---7.84K | 21.93%-629.76K | ---226.35K | ---161.28K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -318.28%-551.8K | -2,136.68%-175.24K | -488.06%-3.7M | -1,194.01%-2.93M | -89.82%-306.15K | -7.76%-131.92K | -7.84K | 21.93%-629.76K | -226.35K | -161.28K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -318.28%-551.8K | -2,136.68%-175.24K | -488.06%-3.7M | -1,194.01%-2.93M | -89.82%-306.15K | -7.76%-131.92K | -7.84K | 21.93%-629.76K | -226.35K | -161.28K |
| Diluted earnings per share | 0 | 0 | -723.55%-0.04 | -1,193.70%-0.0226 | -89.79%-0.0024 | -7.73%-0.001 | -0.0001 | 21.93%-0.0049 | -0.0017 | -0.0012 |
| Basic earnings per share | 0 | 0 | -723.55%-0.04 | -1,193.70%-0.0226 | -89.79%-0.0024 | -7.73%-0.001 | -0.0001 | 21.93%-0.0049 | -0.0017 | -0.0012 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.